Kondru, Naveen
Manne, Sireesha
Greenlee, Justin
West Greenlee, Heather
Anantharam, Vellareddy
Halbur, Patrick
Kanthasamy, Arthi
Kanthasamy, Anumantha
Article History
Received: 5 October 2016
Accepted: 19 January 2017
First Online: 24 February 2017
Competing interests
: A.G.K. and V.A. are shareholders of PK Biosciences Corporation (Ames, IA), which is interested in developing therapeutic strategies for protein misfolding diseases including prion disease. Other authors declare no potential conflicts of interest.